Status:
UNKNOWN
Telemedically Assisted Sampling of COVID-19 Patients - Is the Sampling Quality Sufficient
Lead Sponsor:
Teststation Praxis Dr. med Bielecki
Conditions:
Telemedicine
Pharynx
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
The Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-COV-2) pandemic has resulted in more than 3.8 billion registered tests, 275 million positive cases, and 5 million deaths worldwide. Early and ...
Detailed Description
BACKGROUND AND PROJECT RATIONALE The Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-COV-2) pandemic has resulted in more than 3.8 billion registered tests, 275 million positive cases, and 5 mi...
Eligibility Criteria
Inclusion
- Written informed consent
- Patients visiting the test-station for a SARS-CoV-2 test
- Consent to comply with the study protocol
- Age of 18 or older
Exclusion
- Refusal to comply with the study protocol
- Digital illiteracy (i.e. patients who would never use telemedicine as they do not feel competent enough to use the necessary tools)
- Not German or English speaking
- People trained in the use of rapid diagnostic tests (HCP, biologists) will be excluded to reduce bias
Key Trial Info
Start Date :
April 14 2022
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
December 31 2025
Estimated Enrollment :
170 Patients enrolled
Trial Details
Trial ID
NCT05386407
Start Date
April 14 2022
End Date
December 31 2025
Last Update
April 12 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Teststation Praxis Dr. med Bielecki
Olten, Canton of Solothurn, Switzerland, 4600